G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.75
-0.10 (-0.31%)
May 29, 2026, 1:30 PM CST

G&E Herbal Biotechnology Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
117.55139.2102.0672.47.38-19.88
Depreciation & Amortization
10.6510.6110.389.339.49.33
Other Amortization
-----0
Loss (Gain) From Sale of Assets
0.030.030.010.0100.02
Other Operating Activities
-0.3112.3222.517.980.711.67
Change in Accounts Receivable
-8.580.74-3.04-14.194.381.08
Change in Inventory
-1.23-3.591.21.74-5.69-2.85
Change in Accounts Payable
0.56-0.551.42-22.47-0.35
Change in Unearned Revenue
-95.12-85.1-10.0123.3971.390.28
Change in Other Net Operating Assets
-12.26-3.4910.164.829.921.52
Operating Cash Flow
11.3170.18134.68113.4899.96-9.19
Operating Cash Flow Growth
-93.62%-47.89%18.68%13.52%--
Capital Expenditures
-3.75-3.2-5.92-5.52-2.95-1.77
Sale (Purchase) of Intangibles
---0.08--0.01-0.22
Investment in Securities
35-95.61-83.05-82.045.49
Other Investing Activities
---0.19-0.870.07-
Investing Cash Flow
31.25-98.82-89.24-88.432.517.01
Long-Term Debt Repaid
--0.88-0.77-0.12--
Net Debt Issued (Repaid)
-0.88-0.88-0.77-0.12--
Common Dividends Paid
-44.66-44.66-31.76---
Financing Cash Flow
-45.54-45.53-32.54-0.12--
Net Cash Flow
-2.98-74.1712.924.94102.47-2.18
Free Cash Flow
7.5666.98128.76107.9697.01-10.96
Free Cash Flow Growth
-95.59%-47.98%19.26%11.29%--
Free Cash Flow Margin
2.89%21.67%51.70%59.50%150.15%-44.61%
Free Cash Flow Per Share
0.121.052.021.691.52-0.17
Cash Interest Paid
0.030.030.040--
Cash Income Tax Paid
6.776.770.150.02--
Levered Free Cash Flow
-27.6122.6282.3567.8893.19-5.52
Unlevered Free Cash Flow
-27.5922.6482.3767.8893.19-5.52
Change in Working Capital
-116.62-91.98-0.2813.7682.47-0.32